Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease.
about
Human conditions of insulin-like growth factor-I (IGF-I) deficiencyThe role of bone marrow derived-mesenchymal stem cells in attenuation of kidney function in rats with diabetic nephropathy.Angiogenesis and chronic kidney disease.Renal microvascular injury in chronic aristolochic acid nephropathy and protective effects of Cozaar.Chotosan ameliorates cognitive and emotional deficits in an animal model of type 2 diabetes: possible involvement of cholinergic and VEGF/PDGF mechanisms in the brain.Haemodynamics in microvascular complications in type 1 diabetes.Diabetic kidney disease: impact of puberty.Longitudinal relation between limited joint mobility, height, insulin-like growth factor 1 levels, and risk of developing microalbuminuria: the Oxford Regional Prospective Study.Regulator of Calcineurin 1 Isoform 4 (RCAN1.4) Is Overexpressed in the Glomeruli of Diabetic MiceCharacterization of a new animal model of metabolic syndrome: the DahlS.Z-Lepr(fa)/Lepr(fa) rat.Novel roles of the IGF-IGFBP axis in etiopathophysiology of diabetic nephropathy.New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology.Long-term monitoring of insulin-like growth factor I in adult growth hormone deficiency: a critical appraisal.Agents in development for the treatment of diabetic nephropathy.Endothelial dysfunction and microvascular complications in type 1 diabetes mellitus.Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathyIn skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.Increased functional and structural skin capillary density in type 1 diabetes patients with vascular complications.Pegvisomant: current and potential novel therapeutic applications.Matrix Metalloproteinases-7 and Kidney Fibrosis.Taurine alleviates the progression of diabetic nephropathy in type 2 diabetic rat model.Growth factors in diabetic complications.Endothelial dysfunction, inflammation, and apoptosis in diabetes mellitus.Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line.Cardiovascular dementia - a different perspective.Benazepril hydrochloride improves diabetic nephropathy and decreases proteinuria by decreasing ANGPTL-4 expression.Determination of ghrelin immunoreactivity in kidney tissues of diabetic rats.Bradykinin reduces growth factor-induced glomerular ERK1/2 phosphorylation.The effect of growth hormone on the development of diabetic kidney disease in rats.Estrogen receptor alpha-mediated events promote sex-specific diabetic glomerular hypertrophy.Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.Transforming growth factor beta at clinical onset of Type 1 diabetes mellitus. A pilot study.Dissociation of renal TGF-beta and hypertrophy in female rats with diabetes mellitus.Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.Upper airway loading induces growth retardation and change in local chondrocyte IGF-I expression is reversed by stimulation of GH release in juvenile rats.Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine kinase.Simvastatin alleviates diabetes-induced VEGF-mediated nephropathy via the modulation of Ras signaling pathway.Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
P2860
Q26822806-24D1FD18-B92E-45E8-962B-962E1312D453Q33557060-9F4C5B41-44BE-4B18-B679-F4DC0549AB9DQ34075013-33528C1C-EB2A-4807-9D26-5D1C8C7D7408Q34086068-44548B11-DE83-4297-8112-25DD7D26C555Q34452590-F9FB193E-0130-446E-BD31-C7DF83F570C8Q34804249-7EB54DAE-E87C-49C7-BE83-F64CF8CB5718Q34826667-26D51D93-33C9-4DC9-8767-961A84EC44FAQ35281076-538DFC65-18D3-4F83-B875-455A49CF8DA1Q35569376-8A6FB47E-DEDF-4B3B-A583-F0695CFAA6F0Q35825637-52388833-8A09-47B1-AA0B-0F90DF3AA6AFQ35844164-05C06F3C-E676-4194-8DA3-25D8F4B44923Q35988000-53F890F5-7C8F-4613-97AF-9A1727572E5BQ36068064-8D688D92-7D61-4BC2-95CC-28D2B800223FQ36099419-64E4E6A6-9996-4F7F-B49F-3FF7CA145710Q36854450-8B25B849-5C52-4B99-A5F0-61C67E79BA06Q37069135-72B9684F-7FC3-4A7F-8CC2-86ED1B999D84Q37142827-0F7CD00D-AE67-4F9F-9C1C-573CA44C94D6Q37477850-6F5E6B7A-5DB6-4CE3-862D-8B95438A9835Q37633543-541B811C-9AC6-405F-A6E9-FFC63D365FA6Q37634712-221389A7-B4C5-4C9A-9000-C4A75CEE20F7Q37636034-D514C546-BB30-44FF-A76D-CE1C5E72B660Q37754528-732A985E-BA83-46D1-BC98-BD1868238330Q37773162-7AFB585F-1EF0-4097-A4F7-3B2AE42CD7E3Q38317272-F72A38AD-40A2-44E7-8004-E8E1BDCDFB21Q39780036-91214A6C-1377-4FC6-B7CF-F9FBEA4B41E8Q39994659-3C6BFF10-7A82-415D-8187-00AEF795724BQ40361355-905AD6CB-F343-4400-AA01-B31BA8D1825FQ42154701-308BD1A1-564B-4ECC-9738-7FB47F213B86Q43258995-6A97B8B6-8449-4614-A905-863B9E4B7FBBQ44185814-6102C5E2-7B18-4768-833C-A2242658C4C1Q44362318-1C8078AC-3445-470D-A240-78652F92A0CFQ44901020-BFECA19F-A889-4045-9E51-58803E492F12Q44904255-ACE884BF-16B3-43BE-8A9A-FA4A804C7AA7Q44990816-F975ECCC-403F-4343-856E-F0E85AC9F625Q44997542-659F59DE-3988-449D-9671-EFAC2E19E93EQ45237925-53E07C78-CADA-4FDC-802F-1B1153F698E6Q46372723-61A4C698-C5A6-4AFB-B965-F7145F0032B6Q46508745-2FBF2F60-3DAB-480F-B988-6C8D1A0C86CDQ46526929-FC009A55-F48B-4812-BFBC-A5D5C4E4E6B1Q46717201-98C0381D-D5EF-40A6-842F-0F06A1BDEE44
P2860
Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Putative pathophysiological ro ...... ental diabetic kidney disease.
@ast
Putative pathophysiological ro ...... ental diabetic kidney disease.
@en
Putative pathophysiological ro ...... ental diabetic kidney disease.
@nl
type
label
Putative pathophysiological ro ...... ental diabetic kidney disease.
@ast
Putative pathophysiological ro ...... ental diabetic kidney disease.
@en
Putative pathophysiological ro ...... ental diabetic kidney disease.
@nl
prefLabel
Putative pathophysiological ro ...... ental diabetic kidney disease.
@ast
Putative pathophysiological ro ...... ental diabetic kidney disease.
@en
Putative pathophysiological ro ...... ental diabetic kidney disease.
@nl
P356
P1433
P1476
Putative pathophysiological ro ...... ental diabetic kidney disease.
@en
P2093
Flyvbjerg A
P2888
P304
P356
10.1007/S001250051515
P577
2000-10-01T00:00:00Z
P5875
P6179
1001930749